diabetes forward
Trial Closed

Dear Diabetes FORWARD participant,

Sanofi is committed to helping patients and providers to manage diabetes better and achieve improved outcomes. Conducting research is an important part of this commitment. It is critical when investing in studies that they will provide meaningful results for the medical community. It is therefore with great regret, that we must inform you of Sanofi’s recent decision to discontinue Diabetes FORWARD due to low participation which has prevented the study from achieving its initial objectives and has resulted in an inability to obtain meaningful results.

At this time all patient registration has ended and no further data will be collected. If you were a participating patient that completed a survey and have not yet received your gift card you can expect to receive this within 6 to 8 weeks of completion of the survey. If you do not receive your card please contact support@mediguard.org or by phone at 1-877-244-8273.

Despite the fact that the study closed prematurely, valuable information has still been gathered thanks to your participation and commitment to the study. This will help in planning future diabetes research. We sincerely thank you for your contribution to Diabetes FORWARD.